GenXAI Analytics IPO Final Day: GMP ₹3 (₹-1)

Well, here we are, folks! It’s Day 5, the closing day for the GenXAI Analytics SME IPO on the NSE. The much-anticipated subscription numbers are finally in, and it’s a mixed bag. As the clock ticks down, investors are making their final decisions. Let’s dive into what the subscription data and the Grey Market Premium (GMP) are telling us today.

Subscription Status

The subscription figures for GenXAI Analytics on its closing day are, to put it mildly, quite subdued. We’re seeing 0x subscription across all categories – Retail, Non-Institutional Investors (NII), and Qualified Institutional Buyers (QIB). This is certainly a departure from what many might have expected, especially for an SME IPO aiming for broader participation. A zero subscription across the board on the final day is unusual and could indicate a lack of strong demand or perhaps a wait-and-watch approach from potential investors. Typically, by the closing day, we’d expect to see at least some traction, even if it’s not fully subscribed. The absence of any bids in any category right up to the wire is something that seasoned investors will be scrutinizing closely. It doesn’t necessarily mean the IPO will fail, but it certainly suggests a cautious market sentiment towards this particular offering at the current issue price of ₹110.

GMP Update

Moving on to the Grey Market Premium (GMP), it’s also seen a slight dip. The current GMP is standing at ₹3, down from yesterday’s ₹4. This represents a ₹1 decrease. While a ₹3 GMP isn’t exactly setting the world on fire, it’s still positive, indicating that the market expects the stock to list at a premium to its issue price. The expected listing price, based on the current GMP and the issue price of ₹110, is around ₹113. However, the decrease from ₹4 to ₹3 is a small signal, but it’s one to note. It suggests that the sentiment in the unofficial market might be cooling slightly, or perhaps the lack of subscription is starting to weigh on traders’ minds. It’s important to remember that GMP is not a definitive indicator, but it often gives us a pulse on market sentiment.

Should You Apply?

So, the big question: should you still consider applying for GenXAI Analytics IPO on its closing day? The subscription numbers are undeniably the biggest concern here. Zero subscription across all categories on the final day is a strong indicator of weak demand. This could mean that investors are not convinced about the valuation at ₹110 per share, or perhaps the company’s fundamentals, as perceived by the market, aren’t strong enough to warrant immediate interest. That said, the GMP, though reduced, still points towards a listing gain. The expected listing at ₹113 is a modest premium. For risk-averse investors, the lack of subscription might be a red flag, suggesting it’s better to stay away and wait for more clarity or for the stock to trade on the exchange. For those with a higher risk appetite and who believe in the long-term prospects of GenXAI Analytics, a very low subscription could even mean a higher chance of allotment if they decide to bid. However, it’s always wise to consult with SEBI registered investment advisors before making any investment decisions. Remember, the IPO period is from 2026-06-05 to 2026-06-09. The bottom line is, proceed with extreme caution given the current subscription data.

View Full GenXAI Analytics IPO Details